AI-powered medical search engine that delivers synthesized, cited answers from peer-reviewed research for clinicians.
DrugCard
$1Starting price
7.2KMonthly visits
14Popularity
About DrugCard
DrugCard revolutionizes pharmacovigilance, offering AI-driven solutions for local literature screening. Designed for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers, it simplifies the complex task of monitoring drug safety across multiple regions and languages. Key Features: AI-Enabled Data Intelligence: Utilizes advanced AI algorithms to streamline pharmacovigilance processes, ensuring comprehensive drug safety monitoring. Multi-Language Support: Capable of screening medical literature in over 100 languages, making it a versatile tool for global use. OCR Technology: Proprietary OCR technology delivers up to 99% accuracy, even with poorly scanned texts, ensuring reliable data extraction. Scalable and Flexible: Easily adapts to new markets and integrates additional journals within 2-3 weeks, supporting multi-region operations. DrugCard stands out with its AI-enabled data intelligence, a game-changer for pharmacovigilance. Its ability to process literature in over 100 languages and achieve high accuracy with poorly scanned texts sets it apart, making it an indispensable tool for global drug safety monitoring.
Key features
- AI-Enabled Data Intelligence
- Multi-Language Support
- OCR Technology
- Scalable and Flexible
- Time Efficiency
- High Accuracy
- Cost-Effective
- Improved Compliance
Use cases
- Contract Research Organizations (CROs) for pharmacovigilance projects
- Marketing Authorization Holders (MAHs) for in-house and outsourced literature screening processes
- Pharmacovigilance Freelancers for saving time and resources
Pros
- AI-powered automation for pharmacovigilance and literature screening
- Supports over 100 languages and 146+ countries for global drug safety monitoring
- Proprietary OCR technology with high accuracy for poorly scanned texts
- Scalable and adaptable to new markets and journals within weeks
- Reduces manual workload by 50-70% compared to traditional methods
Cons
- Requires initial setup and onboarding for new users
- Dependence on digital tools may limit flexibility for some traditional workflows
DrugCard videos
Frequently asked questions about DrugCard
What is DrugCard and what does it do?
DrugCard provides AI-powered pharmacovigilance automation for global and local literature monitoring and regulatory intelligence, streamlining drug safety routines for organizations.
Who is DrugCard designed for?
The platform is designed for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers involved in pharmacovigilance and drug safety monitoring.
How many languages does DrugCard support for literature screening?
DrugCard supports screening medical literature in over 100 languages, enabling global and multi-regional pharmacovigilance operations.
Can DrugCard integrate with existing pharmacovigilance systems?
Yes, DrugCard is designed to be scalable and adaptable, allowing integration with existing pharmacovigilance workflows and systems.
What are the key benefits of using DrugCard for pharmacovigilance?
Key benefits include time savings, improved accuracy, traceability, transparency, and scalability to new markets, reducing manual workload and enhancing compliance.
How does DrugCard handle poorly scanned or low-quality texts?
DrugCard uses proprietary OCR technology that delivers high accuracy, even with poorly scanned texts, ensuring reliable data extraction for pharmacovigilance monitoring.
DrugCard Website Engagement
Last Update: 9 days ago
Total Monthly Visits
0
Bounce Rate
0%
Visit Duration (avg)
0.00s
Pages Per Visit
0
Country Rank
0
United States
Global Rank
0
Monthly Traffic
Traffic Sources
Traffic Share By Country
- United States45.7%
- India20.3%
- United Kingdom12.8%
- Canada12.5%
- Poland7.1%
